Andreas Pahl

6PUBLICATIONS
35CO-AUTHORS
Molecular targetsPredictive and prognostic markersGlycoconjugatesProteins and peptidesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 17, 2026
Amanitin-Based Fc-Small Molecule Drug Conjugates with Non-Cleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy.

Daniela Carraturo, Francesca Gallo, Marisa Schmitt

|Nov 20, 2024
Novel Amanitin-Based Antibody-Drug Conjugates Targeting TROP2 for the Treatment of Pancreatic Cancer.

Eleni Papacharisi, Alexandra C Braun, Marija Vranic

|Oct 23, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.

Marc Lopez, Emerence Crompot, Emmanuelle Josselin

|Aug 30, 2021
Iodine-Mediated Tryptathionine Formation Facilitates the Synthesis of Amanitins.

Guiyang Yao, Caroline H Knittel, Simone Kosol

|May 31, 2021
Design, Synthesis, and Biochemical Evaluation of Alpha-Amanitin Derivatives Containing Analogs of the trans-Hydroxyproline Residue for Potential Use in Antibody-Drug Conjugates.

Kaveh Matinkhoo, Antonio A W L Wong, Chido M Hambira

|Mar 23, 2021
Enhancing the Pharmacokinetics and Antitumor Activity of an α-Amanitin-Based Small-Molecule Drug Conjugate via Conjugation with an Fc Domain.

Francesca Gallo, Barbara Korsak, Christoph Müller

Pageof 1

Frequent Collaborators

3 joint publications

Torsten Hechler

1 joint publications

Eleni Papacharisi

1 joint publications

Alexandra C Braun

1 joint publications

Marija Vranic